“Low dose (d1-5/7) oral etoposide regimen in intensively treated platinum-resistant epithelial ovarian cancer: The İzmir oncology group (IZOG) study ” (2021) Annals of Medical Research, 27(1), pp. 0029–0033. Available at: http://annalsmedres.org/index.php/aomr/article/view/591 (Accessed: 4 April 2025).